Cogstate Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Cogstate şirketinin toplam hissedar öz sermayesi $40.9M ve toplam borcu $109.4K olup, bu da borç-öz sermaye oranını 0.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $57.8M ve $16.9M dir. Cogstate 'in FAVÖK'ü $6.2M faiz karşılama oranı 120.5 dur. Şirketin $30.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

0.3%

Borç/özkaynak oranı

US$109.43k

Borç

Faiz karşılama oranı	120.5x
Nakit	US$30.12m
Eşitlik	US$40.92m
Toplam yükümlülükler	US$16.92m
Toplam varlıklar	US$57.84m

Son finansal sağlık güncellemeleri

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29

Recent updates

Pinning Down Cogstate Limited's (ASX:CGS) P/E Is Difficult Right Now

Aug 30

There's Been No Shortage Of Growth Recently For Cogstate's (ASX:CGS) Returns On Capital

Jul 26

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Mar 23

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Mar 02

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Jan 13

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Oct 04

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Sep 28

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Sep 02

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Jun 30

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Mar 22

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Oct 20

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Jul 23

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Mar 14

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

Feb 21

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Jan 17

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Dec 05

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CGS 'nin kısa vadeli varlıkları ( $43.5M ) kısa vadeli yükümlülüklerini ( $12.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: CGS şirketinin kısa vadeli varlıkları ( $43.5M ) uzun vadeli yükümlülüklerini ( $4.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CGS şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: CGS 'nin borç/öz sermaye oranı son 5 yılda 5% seviyesinden 0.3% seviyesine düştü.

Borç Kapsamı: CGS 'nin borcu işletme nakit akışı ( 5286.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: CGS 'in borcuna ilişkin faiz ödemeleri EBIT ( 120.5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Cogstate Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Cogstate (ASX:CGS) Using Too Much Debt?

Recent updates

Cogstate Appoints Kaycee Sink as Chief Medical Officer

CEO, MD & Executive Director exercised options to buy AU$965k worth of stock.

New minor risk - Market cap size

Pinning Down Cogstate Limited's (ASX:CGS) P/E Is Difficult Right Now

Non-Executive Chairman recently bought AU$108k worth of stock

Full year 2024 earnings: EPS exceeds analyst expectations

Cogstate Limited Provides Financial Guidance for the Fiscal Year 2025

Consensus revenue estimates decrease by 10%, EPS upgraded

There's Been No Shortage Of Growth Recently For Cogstate's (ASX:CGS) Returns On Capital

If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity

First half 2024 earnings released: EPS: US$0.012 (vs US$0 in 1H 2023)

Price target decreased by 8.1% to AU$1.70

Investor sentiment deteriorates as stock falls 17%

The Price Is Right For Cogstate Limited (ASX:CGS)

Cogstate Limited to Report First Half, 2024 Results on Feb 22, 2024

Price target increased by 8.6% to AU$1.85

Cogstate Limited Provides Revenue Guidance for 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Now 21% undervalued

Price target decreased by 9.0% to AU$1.70

Now 23% undervalued

Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023

Consensus EPS estimates increase by 12%

Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Consensus revenue estimates increase by 11%

Investor sentiment deteriorates as stock falls 16%

CEO, MD & Executive Director recently bought AU$100k worth of stock

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

First half 2023 earnings released: EPS: US$0 (vs US$0.024 in 1H 2022)

Consensus EPS estimates increase by 23%, revenue downgraded

Investor sentiment deteriorates as stock falls 25%

Now 24% undervalued

Cogstate Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 22% undervalued

Cogstate Limited Announces Resignation of David Dolby as Non-Executive Director

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Price target decreased to AU$1.92

High number of new and inexperienced directors

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Price target decreased to AU$2.18

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$2.41

Cogstate Limited Provides Earnings Guidance for the Fiscal Year 2023

High number of new and inexperienced directors

Price target decreased to AU$2.43

Investor sentiment improved over the past week

High number of new and inexperienced directors

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Cogstate Announces Formation of Scientific Advisory Board

Consensus EPS estimates fall by 82%

Investor sentiment improved over the past week

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Independent Non-Executive Director exercised options to buy AU$244k worth of stock.

Non-Executive Chairman recently sold AU$89k worth of stock

Non-Executive Chairman exercised options and sold AU$188k worth of stock

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.031 (vs US$0.008 loss in FY 2020)

Insider recently sold AU$1.8m worth of stock

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Insider recently sold AU$1.3m worth of stock

Is Cogstate (ASX:CGS) Using Too Much Debt?

CEO, MD & Executive Director exercised options to buy AU$679k worth of stock.

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Cogstate Announces Company Secretary Changes

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like